Competition for targets, a tougher stance from regulators and uneven performance are likely to create an uneasy environment for healthcare special purpose acquisition companies in 2022, S&P Global reports. A total of 107 SPACs that listed parts of the healthcare industry as their intended target went public in 2021, according to S&P Global Market Intelligence data. Deal volume picked up in the last four months of the year, with 23 IPOs in November and December. That uptick in volume means more competition for healthcare companies that are mature enough to go public. Read more.
Related Posts
Regulation Creating Cost Barriers for Live-In Home Care Services
After the Obama administration nearly a decade ago included live-in caregivers in U.S. wage and overtime law, the result has been a sharp spike in costs.
December 9, 2021
Telemedicine Technologies and Services Market to Develop Rapidly by 2025
A rise in the geriatric population and increase in prevalence of chronic diseases are likely to drive the market for telemedicine.
February 15, 2022
APP Is Latest Physician Staffing Firm to Fold
Physician staffing firm American Physician Partners (APP) will shutter at the end of the month, the second such staffing group to fall in recent months, according to reports
July 21, 2023
White House Takes on Non-Compete Agreements, Potentially Hurting Home-Based Care Employers: Report
The executive order requests the Federal Trade Commission (FTC) to “ban or limit” non-compete agreements altogether.
August 16, 2021